US Patent 11446398 Regulated biocircuit systems
Patent 11446398 was granted and assigned to Obsidian Therapeutics on September, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Jul, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114463980
Date of Patent
September 20, 2022
0Patent Application Number
160928290
Date Filed
April 11, 2017
0Patent Citations
Patent Primary Examiner
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114463980
Date of Patent
September 20, 2022
0Patent Application Number
160928290
Date Filed
April 11, 2017
0Patent Citations
Patent Primary Examiner
Edits on 1 Apr, 2023
Golden AI
Infobox
Edits on 28 Sep, 2022
Golden AI
Infobox
Edits on 21 Sep, 2022
Golden AI
Edits made to:
Infobox (+16 properties)
Article (+201 characters)
US Patent 11446398 Regulated biocircuit systems
Article
The present invention provides regulatable biocircuit systems. Such systems provide modular and tunable protein expression systems in support of the discovery and development of therapeutic modalities.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114463980
Date of Patent
September 20, 2022
0Patent Application Number
160928290
Date Filed
April 11, 2017
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11446398 Regulated biocircuit systems
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.